Cargando…
The history of neuromyelitis optica. Part 2: ‘Spinal amaurosis’, or how it all began
Neuromyelitis optica (NMO) was long considered a clinical variant of multiple sclerosis (MS). However, the discovery of a novel and pathogenic anti-astrocytic serum autoantibody targeting aquaporin-4 (termed NMO-IgG or AQP4-Ab), the most abundant water channel protein in the central nervous system,...
Autores principales: | Jarius, S., Wildemann, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935230/ https://www.ncbi.nlm.nih.gov/pubmed/31883522 http://dx.doi.org/10.1186/s12974-019-1594-1 |
Ejemplares similares
-
The history of neuromyelitis optica
por: Jarius, Sven, et al.
Publicado: (2013) -
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
por: Trebst, Corinna, et al.
Publicado: (2013) -
Olfactory Dysfunction in Patients with Neuromyelitis Optica
por: Schmidt, Felix, et al.
Publicado: (2013) -
How It All Began
por: Berry, R. Stephen, et al.
Publicado: (2020) -
The initial steps in pulmonary rehabilitation: How it all began?
por: Vaishali, K, et al.
Publicado: (2019)